Craneware (LON:CRW) Stock Crosses Below Two Hundred Day Moving Average – Time to Sell?

Craneware plc (LON:CRW)’s stock price crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 1,966.26 ($26.17) and traded as low as GBX 1,920 ($25.55). Craneware shares last traded at GBX 1,940 ($25.82), with a volume of 28,233 shares trading hands.

Wall Street Analyst Weigh In

Several research firms have commented on CRW. Shore Capital reiterated a “buy” rating on shares of Craneware in a research note on Thursday, May 8th. Berenberg Bank reiterated a “buy” rating and issued a GBX 2,800 ($37.26) price objective on shares of Craneware in a research note on Tuesday, March 11th.

Craneware Trading Down 1.0%

The firm has a fifty day moving average of GBX 1,725.10 and a two-hundred day moving average of GBX 1,966.08. The company has a market cap of £825.30 million, a PE ratio of 70.97 and a beta of 0.28. The company has a current ratio of 0.63, a quick ratio of 1.00 and a debt-to-equity ratio of 12.22.

Craneware Cuts Dividend

The firm also recently announced a dividend, which was paid on Thursday, April 17th. Shareholders of record on Thursday, March 20th were given a dividend of GBX 13.50 ($0.18) per share. The ex-dividend date of this dividend was Thursday, March 20th. This represents a yield of 0.71%. Craneware’s dividend payout ratio is presently 107.14%.

Insider Activity

In other Craneware news, insider Will Whitehorn acquired 1,911 shares of Craneware stock in a transaction that occurred on Thursday, April 24th. The stock was acquired at an average cost of GBX 1,584 ($21.08) per share, for a total transaction of £30,270.24 ($40,285.12). Insiders own 19.28% of the company’s stock.

Craneware Company Profile

The Craneware Group, the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group’s Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care.